Song et al. applied a lipid-protamine-DNA (LPD) nanoparticle for tumor tissue-specific expression of checkpoint inhibition proteins (PD-L1 trap) to reduce the irAEs of anti-PD-L1 antibodies (Song et al., 2018a). The gene discussed is CD274; the disease is neoplasm.